Special Issue "Hematological Neoplasms: From Diagnosis to Treatment"

Dear Colleagues,

Remarkable progress has been made in the field of hematological oncology. Various immunologic features and genetic abnormalities have been identified for different hematologic malignancies. These findings have contributed to the accurate diagnosis, establishment, and update of the risk classification of various diseases. The assessment of immunological and genetic abnormalities is sometimes useful for selection of the appropriate therapeutic drug and to monitor measurable residual disease during treatment. In addition, targeted therapy has also made substantial progress. The treatment response and prognosis for many diseases that were previously challenging to improve with chemotherapy have since shown improvements. In particular, immune therapy—such as chimeric antigen receptor T-cell therapy and bispecific T-cell engager molecule therapy—has improved the treatment outcome for relapsed or refractory diseases. In this Special Issue, we welcome authors to submit papers on the clinical advancements in hematological oncology regarding diagnosis and treatment.

Dr. Atsushi Satake
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• hematological malignancy
• diagnosis
• risk classification
• measurable residual disease
• targeted therapy
• immune therapy